Search

everythinglearnresearchcommunity

for

Search:↓

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

EF and PXE not closely related.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Eflornithine cream makes laser hair removal more effective for treating pseudofolliculitis barbae.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Fludalanine failed as an effective oral antibiotic despite efforts.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.